[{"orgOrder":0,"company":"Benuvia","sponsor":"Medra Brasil Medicamentos","pharmaFlowCategory":"D","therapeuticArea":"Gastroenterology","country":"U.S.A","productType":"Small molecule","year":"2024","type":"Licensing Agreement","leadProduct":"Tetrahydrocannabinol","moa":"","graph1":"Gastroenterology","graph2":"Approved","graph3":"Benuvia","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"","sponsorNew":"Benuvia \/ Medra Brasil Medicamentos","highestDevelopmentStatusID":"12","companyTruncated":"Benuvia \/ Medra Brasil Medicamentos"},{"orgOrder":0,"company":"Benuvia","sponsor":"Avernus Pharma","pharmaFlowCategory":"D","therapeuticArea":"Nutrition and Weight Loss","country":"","productType":"Small molecule","year":"2024","type":"Licensing Agreement","leadProduct":"Tetrahydrocannabinol","moa":"","graph1":"Gastroenterology","graph2":"Approved","graph3":"Benuvia","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"","sponsorNew":"Benuvia \/ Avernus Pharma","highestDevelopmentStatusID":"12","companyTruncated":"Benuvia \/ Avernus Pharma"}]

Find Clinical Drug Pipeline Developments & Deals by Benuvia

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          ELCC
                          Not Confirmed
                          ELCC
                          Not Confirmed

                          Details : Under the terms of the licensing agreement, Avernus will become the supplier for Syndros (dronabinol). It is indicated for treating anorexia associated with weight loss in patients with AIDS.

                          Product Name : Undisclosed

                          Product Type : Small molecule

                          Upfront Cash : Undisclosed

                          December 10, 2024

                          Lead Product(s) : Tetrahydrocannabinol

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Approved

                          Sponsor : Avernus Pharma

                          Deal Size : Undisclosed

                          Deal Type : Licensing Agreement

                          blank

                          02

                          ELCC
                          Not Confirmed
                          ELCC
                          Not Confirmed

                          Details : Medra Brasil will become the exclusive supplier for Syndros (dronabinol), oral solution, CII in the country of Brazil following approval by the Brazilian Health Regulatory Agency (Anvisa).

                          Product Name : Syndros

                          Product Type : Small molecule

                          Upfront Cash : Undisclosed

                          November 21, 2024

                          Lead Product(s) : Tetrahydrocannabinol

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Approved

                          Sponsor : Medra Brasil Medicamentos

                          Deal Size : Undisclosed

                          Deal Type : Licensing Agreement

                          blank